The new shingles vaccine Shingrix is a far-superior vaccine (97% effective) compared to the old vaccine (60%). It is recombinant, not live, so there are no restrictions in terms of immunosuppression. You can read more about Shingrix at the CDC's website here: https://www.cdc.gov/vaccines/vpd/shingles/public/shingrix/index.html UPDATE as of November 15, 2018: There is presently a global shortage of Shingrix. We are now back-ordered and are keeping a waiting list; we can let y